Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: Addiction. 2017 Feb 8;112(6):1036–1044. doi: 10.1111/add.13753

Table 1.

Participant characteristics overall, and by treatment group.

Characteristic TAU (N=26) XR-NTX (N=25) Total (N=51)

Female Gender 8 (31%) 14 (56%) 22 (43%)

Age, Mean (SD) 45 (12) 47 (8.8) 46 (10)

Hispanic Ethnicity 3 (12%) 1 (4%) 4 (8%)

Race
 Black/African American 12 (46%) 12 (48%) 24 (47%)
 White 9 (35%) 4 (16%) 13 (26%)
 Other 5 (19%) 9 (36%) 14 (27%)

Education completed
 < High school 8(31%) 12 (48%) 20 (39%)
 High school/GED 7(27%) 8(32%) 15(29%)
 ≥ Some college 11(42%) 5(20%) 16 (32%)

Married or living with partner 2 (8%) 6 (24%) 8 (16%)

Employment
 Working now 4 (15%) 3 (12%) 7 (14%)
 Looking for work, unemployed 6 (23%) 5 (20%) 11 (22%)
 Disabled 10 (38%) 13 (52%) 23 (45%)
 Other 6 (23%) 4 (16%) 10 (20%)

Substance Use Disorder
 Opioid use disorder alone 9 (35%) 7 (28.0%) 16 (31%)
 Alcohol use disorder alone 14(54%) 13 (52%) 27 (53%)
 OUD+AUD 3(11%) 5(20%) 8(16%)

ASI drug score .37(SD=.33) .44(SD=.39) .41(SD=.36)

ASI alcohol score .33(SD=.32) .41(SD=.32) .37(SD=.32)

Baseline CD4 Count, mean (SD) 564 (246) 683 (418) 620 (339)

Baseline ART, n (%) 25 (96%) 23 (92%) 48 (94%)

Baseline HIV Viral Suppression, n (%) 21 (81%) 20 (80%) 41 (80%)